Literature DB >> 6291732

Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia.

K Olgaard, M Arbelaez, J Schwartz, S Klahr, E Slatopolsky.   

Abstract

The release of cyclic AMP from bone in response to stimulation with PTH 1-34 was examined in 20 dogs with long-term chronic renal failure (CRF) produced by unilateral nephrectomy and contralateral partial renal artery ligation. After 9 to 15 months of uremia, the tibiae were removed and perfused in vitro. Seven dogs with CRF served as controls, 7 dogs with CRF were treated with 24,25(OH)2D3 - 2.5 micrograms per day, and 6 CRF dogs underwent thyroparathyroidectomy (TPTX) 42 h before they were sacrificed. The release of cyclic AMP from bone in response to PTH 1-34 in the CRF dogs was severely reduced compared to the response observed in 7 dogs with normal renal function (net accumulation of cyclic AMP release 86 +/- 8.5 versus 426 +/- 59.0 pmol/30 min). Long-term treatment of uremic dogs with 24,25(OH)2D3 had no effect on the release of cyclic AMP by bone. However, the release of cyclic AMP was restored to normal levels in the CRF dogs that underwent thyroparathyroidectomy. All CRF dogs had secondary hyperparathyroidism and the fact that TPTX returned the cyclic AMP response to normal values suggests that desensitization to PTH of the adenylate cyclase system of bone exists in chronic uremia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291732     DOI: 10.1007/bf02411275

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  17 in total

1.  Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.

Authors:  K A Hruska; R Kopelman; W E Rutherford; S Klahr; E Slatopolsky; A Greenwalt; T Bascom; J Markham
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 2.  Hormonal regulation of peptide receptors and target cell responses.

Authors:  K J Catt; J P Harwood; G Aguilera; M L Dufau
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

3.  In vitro effects of vitamin D3 metabolites on rat calvaria cAMP content.

Authors:  M Lieberherr; M Garabédian; H Guillozo; C L Thil; S Balsan
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

4.  Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3.

Authors:  S G Massry; R Stein; J Garty; A I Arieff; J W Coburn; A W Norman; R M Friedler
Journal:  Kidney Int       Date:  1976-06       Impact factor: 10.612

5.  The action of vitamin D metabolites (25 OHD3--12,5 (OH)2D3--24.25 (OH)2D3--25.26 (OH)2D3) on vitamin D deficient rats.

Authors:  M L Queille; L Miravet; P Bordier; J Redel
Journal:  Biomedicine       Date:  1978 Jul-Aug

6.  The response to the infusion of parathyroid extract in hypocalcaemic states.

Authors:  J M Evanson
Journal:  Clin Sci       Date:  1966-08       Impact factor: 6.124

7.  Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.

Authors:  P J Somerville; M Kaye
Journal:  Kidney Int       Date:  1978-09       Impact factor: 10.612

8.  Radioimmunoassay for the measurement of adenosine 3',5'-cyclic phosphate.

Authors:  A L Steiner; D M Kipnis; R Utiger; C Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1969-09       Impact factor: 11.205

9.  Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.

Authors:  R Marcus; F B Orner; A S Brickman
Journal:  Endocrinology       Date:  1980-11       Impact factor: 4.736

10.  Peripheral metabolism of intact parathyroid hormone. Role of liver and kidney and the effect of chronic renal failure.

Authors:  K A Hruska; A Korkor; K Martin; E Slatopolsky
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

View more
  3 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Role of PTH1R internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model.

Authors:  Nabanita S Datta; Tareq A Samra; Chandrika D Mahalingam; Tanuka Datta; Abdul B Abou-Samra
Journal:  J Endocrinol       Date:  2010-10-07       Impact factor: 4.286

3.  Osteoporosis: a bone turnover defect resulting from an elevated parathyroid hormone concentration within the bone-marrow cavity?

Authors:  M J Atkinson; T Schettler; H Bodenstein; R D Hesch
Journal:  Klin Wochenschr       Date:  1984-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.